期刊文献+

cyclin D1蛋白表达预测头颈鳞癌预后 被引量:1

Prognostic value of cyclin D1 expression in head and neck squamous cell carcinoma assessed by tissue microarrays
原文传递
导出
摘要 目的:探讨cyclin D1蛋白表达在判断头颈鳞癌患者预后方面的意义。方法 :选取头颈鳞癌患者96例,取肿瘤标本制作组织芯片,应用免疫组化方法检测cyclin D1蛋白的表达情况。蛋白表达与临床病理学参数的关系应用非参数检验(Kruskal-Wallis检验),与预后的关系应用Kaplan-Meier检验和Cox回归多因素生存分析,所有统计学分析均采用SPSS17.0软件包完成。结果:患者平均随访时间为6.2a。Kaplan-Meier生存分析表明,cyclin D1低表达与高表达患者相比预后更好(P=0.009);多因素生存分析表明,cyclin D1蛋白表达是唯一与总生存率密切相关的因子(HR:2.260,95%CI:1.074-4.758;P=0.032)。该蛋白表达与病理分级、临床分期、性别及发病部位等临床病理学参数无关。结论:cyclin D1表达是预测头颈鳞癌患者预后的独立因子,能够作为头颈鳞癌潜在的分子诊断和靶向治疗靶点。 PURPOSE: To explore the prognostic value of cyclin D1 expression in head and neck squamous cell carcinoma(HNSCC).METHODS: Ninety six patients with HNSCC who were treated at the Department of Oral and Maxillofacial Surgery of Ninth people’s Hospital,were enrolled in the study.Tissue microarrays were made using tumor specimen.The expression of cyclin D1 was detected by immunohistochemistry.And the association between cyclin D1 expression and clinicopathologic features was analyzed using Kruskal-Wallis test.Survival curves were calculated using the Kaplan-Meier method.Cox proportional hazard models were utilized for multivariate analyses of cyclin D1 expression and other baseline factors with OS.All calculations and analyses were performed using the SPSS 17.0 software package.RESULTS: The mean follow-up period was 6.2 years.The patients whose tumors showed a lower cyclin D1 expression had a significantly better OS than those whose tumors showed a higher cyclin D1 expression(P=0.009) by Kaplan-Meier method.A multivariate survival analysis also showed that cyclin D1 expression was the sole factor associated with prognosis(HR: 2.260,95% CI:1.074-4.758;P=0.032).But the protein expression was not associated with any clinicopathologic factors,including gender,site,pathological grade and clinical stage.CONCLUSIONS: Cyclin D1 expression is an independent predictive factor for prognosis of HNSCC patients,and may serve as a potential biomarker for molecular diagnosis and targeted therapy in future.
出处 《中国口腔颌面外科杂志》 CAS 2012年第4期277-281,共5页 China Journal of Oral and Maxillofacial Surgery
基金 上海市科学技术委员会资助项目(08JC1414400 10DZ1951300)~~
关键词 头颈部 鳞状细胞癌 CYCLIN D1 组织芯片 预后 Head and neck; Squamous cell carcinoma; Cyclin D1; Tissue microarray; Prognosis
  • 相关文献

参考文献15

  • 1郑家伟,李金忠,钟来平,张志愿.口腔鳞状细胞癌临床流行病学研究现状[J].中国口腔颌面外科杂志,2007,5(2):83-90. 被引量:90
  • 2Stewart BW, Kleihues P. World cancer report: head and neck cancer[M]. Lyon, France: IARC Press, 2003: 232-236.
  • 3Yu Z, Weinberger PM, Haffty BG, et al. Cyclin D1 is a valuable prognostic marker in oropharyngeal squamous cell carcinoma[J]. Clin Cancer Res, 2005, 11(3): 1160-1166.
  • 4Myo K, Uzawa N, Miyamoto R, et al. Cyclin D1 gene numerical aberration is a predictive marker for occult cervical lymph node metastasis in TNM stage I and II squamous cell carcinoma of the oral cavity[J]. Cancer, 2005, 104(12): 2709-2716.
  • 5Huang C, Yang L, Li Z, et al. Detection of CCND1 amplification using laser capture microdissection coupled with real-time polymerase chain reaction in human esophageal squamous cell carcinoma[J]. Cancer Genet Cytogenet, 2007, 175(1): 19-25.
  • 6van't Veer LJ, Bernards R. Enabling personalized cancer medieine through analysis of gene-expression patterns[J]. Nature, 2008, 452(7187): 564-570.
  • 7Strausberg RL, Simpson A J, Old LJ, et al. Oneogenomics and the development of new cancer therapies[J]. Nature, 2004, 429(6990): 469-474.
  • 8Feng Z, Guo W, Zhang C, et al. CCND1 as a predictive biomarker of neoadjuvant chemotherapy in patients with locally advanced head and neck squamous cell carcinoma [J]. PLoS One, 2011, 6(10): e26399.
  • 9Namazie A, Alavi S, Olopade OI, et al. Cyclin D1 amplification and P16 (MTS1/CDK4I) deletion correlate with poor prognosis in head and neck tumors[J]. Laryngoscope, 2002, 112(3): 472-481.
  • 10Kyomoto R, Kumazawa H, Toda Y, et al. Cyclin D1 gene amplification is a more potent prognostic factor than its protein overexpresion in human head and neck squamous cell carcinoma[J]. Int J Cancer, 1997, 74(6):576-581.

二级参考文献72

  • 1付志婕,潘新良,雷大鹏,刘大昱,刘文君,刘春喜,王荣,叶萍.细胞周期素D1和p16在下咽癌中的表达及临床意义[J].临床耳鼻咽喉头颈外科杂志,2007,21(9):406-409. 被引量:10
  • 2Nelson WJ, Nusse R. Convergence of Wnt, β-catenin, and cadherin pathways [J]. Science, 2004,303 (5663):1483- 1487.
  • 3Doucas H, Garcea G, Neal CP, et al. Changes in the Wnt signaling pathway in gastrointestinal cancers and their prognostic significance [J]. Eur J Cancer, 2005,41 (3) :365- 379.
  • 4Su Y, Shrubsole MJ, Ness RM, et al. Immunohistochemical expressions of ki-67, Cyclin D1, beta-Catenin, cyclooxygenase-2 and epidermal growth factor receptorin human colorectal adenoma: a validation study of tissue microarrays [J]. Cancer Epidemiol Biomarkers Prey, 2006,15 (9) : 1719- 1727.
  • 5Wang Y, Liu S, Zhu H, et al. FRAT1 overexpression leads to aberrant activation of beta-catenin/TCF pathway in esophageal squamous cell carcinoma [J]. Int J Cancer, 2008, 123(3) :561-568.
  • 6Tsuehiya R, Yamamoto G, Nagoshi Y, et al. Expression of adenomatous polyposis coli in tumorigenesis of human oral squamous cell carcinoma [ J ]. Oral Oncol, 2004,40 (9) : 932-940.
  • 7Zlobec I, Lugli A, Baker K, et al. Role of APAF-1, et al. E-cadherin and peritumoral lymphocytic infiltration in tumour budding in colorectal cancer [J]. J Pathol, 2007,212(3): 260-268.
  • 8[1]Kufe DW,Holland JF,Frei E,American Cancer Society.Cancer medicine[M].6th Edition.Lewiston:BC Decker,2003:2.
  • 9[2]Mignogna MD,Felele S,Russo LL.The World Cancer Report and the burden of oral cancer[J].Eur J Cancer Prev,2004,13(2):139-142.
  • 10[3]Howell RE,Wright BA,Dewar R.Trends in the incidence of oral cancer in Nova Scotia from 1983 to 1997[J].Oral Surg Oral Med Oral Pathol Oral Radiol Endod,2003,95(2):205-212.

共引文献109

同被引文献5

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部